Other languages Clarus Corporation

Equities

Market Closed - Nasdaq Other stock markets 01:30:00 27/04/2024 am IST			5-day change	1st Jan Change
6.28 ^USD	+3.46%		+0.64%	-8.92%

13/03	Roth MKM Adjusts Price Target on Clarus to $7.50 From $6.50, Maintains Buy Rating	MT
11/03	Transcript : Clarus Corporation - Analyst/Investor Day

Sector Update: Consumer Stocks Slipping in Late Afternoon Trading	09/03
Sector Update: Consumer Stocks Decline in Afternoon Trading	09/03
Clarus Board Approves Requests to Increase Ownership From Two Shareholders; Shares Jump	08/03
Clarus Corporation Appoints Roger Werner to Its Board of Directors	08/03
Clarus Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	08/03
Clarus Corporation Provides Earnings Guidance for the Fiscal Year 2024	08/03
Clarus Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	08/03
Clarus Corporation Announces Regular Quarterly Cash Dividend, Payable on March 28, 2024	06/03
Silynxcom Gets Additional $400,000 Order for Clarus Headset System; Shares Rise	23/01
Clarus Corporation Announces the Resignation of James E. Walker III as a Director	10/01
Sector Update: Consumer Stocks Mixed in Afternoon Trading	03/01
Sector Update: Consumer Stocks Mixed in Late Afternoon Trading	03/01
Sector Update: Consumer Stocks Slip Pre-Bell Tuesday	02/01
Sector Update: Consumer	02/01
Clarus to Sell Precision Sport Segment for $175 Million	30/12
Blackstone explores sale of Anthos Therapeutics -sources	05/12
Blackstone explora la venta de Anthos Therapeutics: fuentes	05/12
Blackstone explores sale of Anthos Therapeutics -sources	05/12
Clarus Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	08/11
Clarus Corporation Provides Earnings Guidance for the Year 2023	08/11

No results for this search